 |
 |
 |
|
HUMAN CONFIRMATION OF ORAL DOSE REDUCTION POTENTIAL OF NANOPARTICLE ANTIRETROVIRAL FORMULATIONS
|
|
|
Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle, WA
Andrew Owen, Steve Rannard, AkilJackson, Laura Dickinson, Marco Giardiello, Marco Siccardi, Paul Domanico, MelyndaWatkins, Yao Cheng, Marta Boffito
WEBCAST:http://www.croiwebcasts.org/console/player/33376?mediaType=slideVideo&






|
|
|
 |
 |
|
|